CG Oncology Financial Ratios for Analysis 2022-2024 | CGON

Fifteen years of historical annual and quarterly financial ratios and margins for CG Oncology (CGON).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
13.629.54
--0.09
--0.20
100.00100.00
-27,180.88-18,453.40
-27,180.88-18,453.40
-28,562.26-18,422.51
-23,826.96-18,556.54
-33,234.31-22,925.65
0.000.00
--
2.220.63
165579
39.4945.62
39.4945.62
-24.39-23.99
39.4949.81
-23.57-20.22
-10.55-7.97
-10.55-7.97

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31
35.3247.5757.9513.62----
--------
--------
100.00100.00100.00-100.00-100.00-
-65,802.33-23,290.99-4,247.45--156,033.30--5,010.83-
-65,802.33-23,290.99-4,247.45--156,033.30--5,010.83-
--------
-47,453.49-17,028.83-3,200.76--130,755.60--4,467.53-
-47,453.49-17,028.83-3,200.76--194,600.00--6,392.27-
0.000.000.000.00----
--------
0.310.613.460.01----
28714826.038,280----
-3.80-3.42-2.9813.45----
-3.80-3.42-2.9813.45----
-3.69-3.35-2.92-8.31----
-3.80-3.42-2.9813.45----
7.958.298.54-23.57----
-0.86-0.63-0.55-10.55-7.08-4.79-2.070.00
-0.86-0.63-0.55-10.55-7.08-4.79-2.07-